Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 15, 2505-2517
Abstract
Purpose: Nesfatin-1 is produced in various tissues of the body including the hypothalamus. Neuroprotective properties of the neuropeptide hormone Nesfatin-1 were recently described. The aim of the study was to analyze the molecule Nesfatin-1 as a possible biomarker in POAG with neuroprotective properties pointing out the retinal-hypothalamic axis as target site in POAG and to obtain a molecular signature of cytokines in POAG as neuroinflammatory processes are a key factor of glaucoma development. Methods: In this study, n=35 patients with moderate and advanced POAG (mean age 65.0y, IOP 13.9 +/- 3.0mmHg) and n=35 healthy controls (mean age 51.6y, IOP 14.3 +/- 2.7mmHg) were included. Clinical parameters including IOP, cup to disc ratio (CDR), glaucoma medication and retinal nerve fiber layer thickness (RNFL) were recorded. Plasma was collected for NUCB2/nesfatin-1 measurement using a Nesfatin-1 ELISA and for detection of 13 inflammatory cytokines using a multiplex bead-based immunoassay (MagPix). Multiple linear regression analysis was performed to adjust for confounding factors. Results: Sex-independent or sex-dependent variables showed no significant differences in the Nesfatin-1 level (p>0.05). As a trend, an increase in NUCB2/nesfatin-1 in male glaucoma patients was found. Increased concentrations of 11 cytokines (GM-CSF, Interferon-gamma, Interleukin-1 beta, IL-2, 4, 5, 6, 7, 10, 12 and TNF-alpha) were detected in POAG. The female glaucoma patients demonstrated elevated cytokine concentrations compared to male patients. NUCB2/nesfatin-1 showed a significant correlation to IL-2 and IL-13 levels in POAG. Stepwise multiple regression analysis showed no difference in NUCB2/nesfatin-1 level between POAG and healthy controls after adjusting for sex and age (all p>0.05). Conclusion: As a trend, male POAG patients showed increased plasma NUCB2/nesfatin-1 levels. We further found inflammation as contributing factor to the pathogenesis of glaucoma, with a greater inflammatory response in women.Keywords
This publication has 51 references indexed in Scilit:
- The Time Course of Gene Expression during Reactive Gliosis in the Optic NervePLOS ONE, 2013
- Dorsomedial/Perifornical Hypothalamic Stimulation Increases Intraocular Pressure, Intracranial Pressure, and the Translaminar Pressure GradientInvestigative Ophthalmology & Visual Science, 2012
- Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucomaJournal of Clinical Investigation, 2012
- Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucomaJournal of Clinical Investigation, 2011
- Serum Cytokine Alteration is Associated With Optic Neuropathy in Human Primary Open Angle GlaucomaJournal of Glaucoma, 2010
- The two sides of cytokine signaling and glaucomatous optic neuropathyJournal of Ocular Biology, Diseases, and Informatics, 2009
- Permeability of the blood–brain barrier to a novel satiety molecule nesfatin-1Peptides, 2007
- Retinal ganglion cell protection by 17‐β‐estradiol in a mouse model of inherited glaucomaDevelopmental Neurobiology, 2007
- Topical BimatoprostDrugs & Aging, 2002
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993